Sodium Cromoglicate

Key Product Details

Product Description

Sodium Cromoglicate is a promotes transformation ESCs/iPSCs into pancreatic endocrine islet cells. Facilitates differentiation from endocrine precursors. Also inhibits mast cell degranulation and histamine release. Antiasthmatic.

Product Specifications for Sodium Cromoglicate

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Solubility

Preparing Stock Solutions for Sodium Cromoglicate

The following data is based on the product molecular weight 512.33.

Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:

1 Recalculate

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.5 mM	3.90 mL	19.52 mL	39.04 mL
2.5 mM	0.78 mL	3.90 mL	7.81 mL
5 mM	0.39 mL	1.95 mL	3.90 mL
25 mM	0.08 mL	0.39 mL	0.78 mL

Calculators

Background References

References are publications that support the biological activity of the product.

• Kondo Identification of a small molecule that facilitates the differentiation of human iPSCS/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells. Diabetologia. 2017 PMID: 28534195
• Orr and Cox Disodium Cromoglycate, an inhibitor of mast cell degranulation and histamine release induced by phospholipase A. Nature. 1969 PMID: 4183038

Product Documents for Sodium Cromoglicate